1. Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Issue 6 (4th January 2007) Authors: Ruiz-Irastorza, G; Ugarte, A; Egurbide, M V; Garmendia, M; Pijoan, J I; Martinez-Berriotxoa, A; Aguirre, C Journal: Annals of the rheumatic diseases Issue: Volume 66:Issue 6(2007) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗